One post from Mindy Hetzer Pelz's dossier. This page reviews a single piece of material. The full dossier cross-checks 23 materials and carries the verified credential and scope verdicts.
Read the full dossier →Mindy Hetzer Pelz alias The Fasting Brain Funnel
YouTube · UC4cNjUPc2gQKucX3hLUayYQ
Practice location
115 PASEO DE SAN ANTONIO
SAN JOSE, CA 95112
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 7 health claims, 2 run counter to or conflict with the published evidence, and 1 was not independently checked.
- Primary persuasion tactic: Borrowed specialist authority.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Mindy Pelz has assembled the deluxe doc-bro sampler: alarming belly-fat headlines, a prestigious guest, a free fasting guide, and a paid event waiting just off-camera. Why stop at discussing brain aging when every metabolic worry can be escorted toward a branded resource and an Amazon checkout?
High grift signals
Score breakdown
Direct answer
Mindy Hetzer Pelz is licensed in California as a chiropractor (DC), not as an MD or DO, and California's chiropractic scope statute (Cal. Code Regs. Tit. 16, § 302(a)(3)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Alzheimer’s disease, The Menopause Reset, and Hormones & Menopause, conditions that belong with endocrinologists. Those same pages route patients toward supplements and paid programs that Mindy Hetzer Pelz profits from.
Key findings
- False Authority: The episode places a guest's medical authority beside the host's title, which can make the host appear equally qualified on Alzheimer’s disease, menopause, hormones, and prescription medications even though the host's own credentials and scope are not established here.see section ↓
- Claim "Women can use HRT, GLP-1 medications, ketones, fasting, fiber, exercise, BDNF, and sleep…": not supported by peer-reviewed evidence.see section ↓
- Claim "Blood sugar, insulin resistance, visceral fat, inflammation, and mitochondrial health inf…": only partially supported.see section ↓
- NPI registry confirms Mindy Pelz as Chiropractor (DC) in California (NPI 1740391564).see section ↓
- Mindy Hetzer Pelz shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Mindy Hetzer Pelz is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against California Board of Chiropractic Examiners scope rules (Cal. Code Regs. Tit. 16, § 302(a)(3)), these advertised activities appear outside Mindy Hetzer Pelz's license (including conditions they merely list as ones they treat): Alzheimer’s disease, Metabolic health is one of the most…see section ↓
- 6 of 6 advertised activities fall outside permitted Chiropractor scope in CA.see section ↓
Claims & evidence
In their own published words, they present themselves as qualified to treat, or give advice on, 6 conditions or treatments. A chiropractic license covers the spine, joints and muscles, and the scope review placed each one outside it. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Alzheimer’s disease.
Alzheimer’s disease
- Supports
- Menopause involves a substantial decline in ovarian estrogen and is associated with changes in brain structure, connectivity, energy metabolism, and amyloid-beta deposition, providing biologic plausibility for increased vulnerability to brain aging. Reviews report that cognitive complaints and some attention, verbal-memory, and working-memory changes commonly increase during the menopause transition, although these changes are often mild or transient. Early menopause and premature ovarian insufficiency have been associated with increased dementia risk in observational meta-analysis, but this does not establish that ordinary menopause causes Alzheimer disease.
- Contradicts
- The listed papers are unrelated clinical-trial registrations and provide no evidence about menopause, brain aging, or Alzheimer disease. Evidence directly linking usual-age menopause to incident Alzheimer disease remains observational and heterogeneous. Cognitive symptoms during menopause do not necessarily represent progressive neurodegeneration, and evidence that menopause hormone therapy prevents dementia is not robust; late-life hormone therapy, particularly estrogen plus progestogen, has been associated with increased dementia risk in randomized trials, while midlife effects remain uncertain.
- Mainstream view
- Menopause is recognized as a period of hormonal and brain changes that may increase susceptibility to cognitive symptoms and possibly later neurodegenerative disease, especially with early menopause or additional risk factors. However, menopause itself is not established as a direct cause of Alzheimer disease, and hormone therapy should not be prescribed solely to prevent dementia. The claim is broadly plausible but should be interpreted as increased vulnerability or risk, not inevitable brain aging or Alzheimer disease.
Papers listed for this claim:[1][2][3][4]
“Women are far more likely than men to develop Alzheimer’s disease”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Dementia and Alzheimer disease
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to advertise Metabolic health is one of the most important pieces of the explanation for women’s Alzheimer’s risk. as within their scope of practice.
Metabolic health is one of the most important pieces of the explanation for women’s Alzheimer’s risk.
- Supports
- Metabolic factors, particularly diabetes, hypertension, obesity, physical inactivity, and abnormal glucose regulation, are recognized modifiable dementia risk factors; the 2024 Lancet Commission includes diabetes, obesity, hypertension, and physical inactivity among targets associated with dementia prevention. A systematic review found that abnormal glucose metabolism, including type 2 diabetes, is associated with increased Alzheimer’s disease risk, although sex-specific conclusions were limited. In a large cohort of older adults with type 2 diabetes, women had higher Alzheimer’s disease incidence than men, and severe hypoglycemia and HbA1c variability predicted Alzheimer’s disease in women but not men. A review of sex-specific evidence reported higher diabetes-associated Alzheimer’s risk estimates in women than men, although findings across studies were not fully consistent.
- Contradicts
- The listed papers do not provide relevant evidence for this claim: they are clinical trial registrations involving type 1 diabetes, rheumatoid arthritis, angioplasty, medical education, heart failure, mHealth, training, or neck pain, rather than studies of women’s metabolic health and Alzheimer’s risk. Evidence for metabolic syndrome as a whole is inconsistent: multiple meta-analyses found no significant association with Alzheimer’s disease specifically, despite associations with all-cause or vascular dementia. A recent meta-analysis similarly found no significant overall association between metabolic syndrome and Alzheimer’s disease, while hyperglycemia and high blood pressure were associated with higher risk. Observational associations do not establish that metabolic health is one of the most important explanations for women’s Alzheimer’s risk, and the claim does not define which metabolic factors, life stage, or comparison are intended.
- Mainstream view
- Metabolic health is an important, modifiable contributor to dementia risk and may be particularly relevant to women because diabetes and some glycemia-related factors can have stronger or sex-specific associations with Alzheimer’s disease. However, women’s Alzheimer’s risk is multifactorial and also involves age, longevity, genetics, vascular health, education, hearing, physical activity, depression, social factors, and potentially hormonal and reproductive factors. The evidence supports describing metabolic health as one important component of the explanation, but not as established one of the most important explanations without qualification or a defined ranking.
Papers listed for this claim:[5][6][7][8]
“one of the most important pieces of that story is metabolic health”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Dementia and Alzheimer disease
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Menopause may increase vulnerability to brain aging or Alzheimer’s disease..
Menopause may increase vulnerability to brain aging or Alzheimer’s disease.
- Supports
- Menopause involves a substantial decline in ovarian estrogen and is associated with changes in brain structure, connectivity, energy metabolism, and amyloid-beta deposition, providing biologic plausibility for increased vulnerability to brain aging. Reviews report that cognitive complaints and some attention, verbal-memory, and working-memory changes commonly increase during the menopause transition, although these changes are often mild or transient. Early menopause and premature ovarian insufficiency have been associated with increased dementia risk in observational meta-analysis, but this does not establish that ordinary menopause causes Alzheimer disease.
- Contradicts
- The listed papers are unrelated clinical-trial registrations and provide no evidence about menopause, brain aging, or Alzheimer disease. Evidence directly linking usual-age menopause to incident Alzheimer disease remains observational and heterogeneous. Cognitive symptoms during menopause do not necessarily represent progressive neurodegeneration, and evidence that menopause hormone therapy prevents dementia is not robust; late-life hormone therapy, particularly estrogen plus progestogen, has been associated with increased dementia risk in randomized trials, while midlife effects remain uncertain.
- Mainstream view
- Menopause is recognized as a period of hormonal and brain changes that may increase susceptibility to cognitive symptoms and possibly later neurodegenerative disease, especially with early menopause or additional risk factors. However, menopause itself is not established as a direct cause of Alzheimer disease, and hormone therapy should not be prescribed solely to prevent dementia. The claim is broadly plausible but should be interpreted as increased vulnerability or risk, not inevitable brain aging or Alzheimer disease.
Papers listed for this claim:[1][2][3][4]
“why menopause may increase vulnerability”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Dementia and Alzheimer disease
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Blood sugar, insulin resistance, visceral fat, inflammation, and mitochondrial health influence brain aging..
Blood sugar, insulin resistance, visceral fat, inflammation, and mitochondrial health influence brain aging.
- Supports
- Observational studies and reviews support associations between diabetes, impaired glucose metabolism, and insulin resistance with cognitive decline, dementia risk, and pathological brain aging. The blood–brain barrier can also undergo age-related and microvascular changes relevant to brain aging . The listed evidence on dietary acid load, fasting blood sugar, and insulin-resistance biomarkers supports their relevance to systemic metabolic health, but does not directly establish effects on brain aging . Exercise evidence supports reductions in visceral fat, a metabolic factor associated with systemic inflammation, but does not directly demonstrate slowed brain aging . Mitochondrial dysfunction is widely regarded as a contributor to neuronal bioenergetic impairment, neuroinflammation, cognitive decline, and age-related neurodegeneration. Overall, the claim is biologically plausible and broadly consistent with associative evidence, especially for glucose dysregulation, insulin resistance, inflammation, and mitochondrial dysfunction.
- Contradicts
- The cited papers do not directly test the combined claim that blood sugar, insulin resistance, visceral fat, inflammation, and mitochondrial health influence brain aging. The visceral-fat paper primarily evaluates exercise-related changes in adiposity rather than brain-aging outcomes , while the fasting-blood-sugar and insulin-resistance papers assess metabolic biomarkers rather than cognition, neurodegeneration, or brain aging . The psyllium meta-analysis concerns glycemic and insulin-resistance outcomes, not brain aging . The vitamin D and visceral-fat study is an abstract and concerns associations among obesity-related biomarkers, without direct brain outcomes . Much of the broader literature is observational or mechanistic, so causality, the magnitude of each factor's independent effect, and whether improving these factors slows brain aging remain uncertain. Associations between brain insulin resistance and Alzheimer pathology are also heterogeneous and not uniformly confirmed.
- Mainstream view
- The mainstream view is that brain aging is multifactorial and is influenced by vascular, metabolic, inflammatory, genetic, lifestyle, and cellular processes. Diabetes and insulin resistance are credible modifiable risk factors for cognitive decline and dementia, and chronic inflammation and mitochondrial dysfunction are plausible contributors to age-related neural deterioration. Visceral fat may contribute indirectly through insulin resistance, inflammation, vascular disease, and metabolic dysfunction, but its independent causal effect on brain aging is less firmly established. These factors should be viewed as associated risk and mechanistic contributors, not as proven single causes or as guarantees that changing one factor will prevent or reverse brain aging.
Papers listed for this claim:[9][10][11][12]
“how blood sugar, insulin resistance, visceral fat, inflammation, mitochondrial health, and lifestyle all influence brain aging”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure The Menopause Reset.
The Menopause Reset
- Supports
- No cited paper evaluates or establishes “The Menopause Reset” as a licensed treatment. Evidence supports licensed, individualized menopause therapies such as menopausal hormone therapy for appropriate patients with vasomotor or genitourinary symptoms, but this does not validate the named program. The International Menopause Society recommends individualized assessment and evidence-based management of midlife health and menopause.
- Contradicts
- The claim provides no identifiable active ingredient, device, protocol, indication, regulator, or jurisdiction, and no evidence shows that “The Menopause Reset” is itself a licensed medical treatment. The listed papers largely concern unrelated obesity, oncology, nicotinamide, or estradiol questions and do not license or validate this named intervention. Standard guidance recognizes specific approved treatments rather than a generic branded reset program.
- Mainstream view
- Menopause should be assessed clinically and treated according to symptoms, age, risks, preferences, and contraindications. Evidence-based options include appropriately prescribed menopausal hormone therapy and selected nonhormonal treatments; a program called “The Menopause Reset” should not be described as a licensed treatment without verifiable regulatory authorization and direct clinical evidence.
Papers listed for this claim:[13][14][15][16][17][18][19][20][21][22][23][24]
“The Menopause Reset”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Menopause
Mindy Hetzer Pelz is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Hormones & Menopause.
Hormones & Menopause
No specific health claims of theirs were cross-checked against the literature.
“Hormones & Menopause”
Rule: Cal. Code Regs. Tit. 16, § 302(a)(3)
See every doc bro who says they can treat or advise on Hormone imbalance and replacement
Manipulation
Commerce & grift map
The visible funnel is fear-tinged brain-aging content leading to a free fasting guide, a book recommendation through Amazon, and paid events or branded resources. The available material does not prove a commission, but the absent on-surface disclosure leaves the audience guessing whether the recommendation is education or monetized placement.
No paid-promotion disclosure appears on this youtube content. Viewers who arrive directly never learn the creator may be compensated by Amazon, Brain Defenders by David Perlmutter.
Amazon
Commerce
Amazon is the retail conduit for the book, but the available source does not establish whether the link earns the host a commission. Vendor page language: "Earn Commissions.Sign up Amazon Associates - Amazon’s affiliate marketing program Welcome to one of the largest affiliate marketing programs in the world."
Doc Bro outbound link (live) · Archive pending
Vendor provider compensation page (live) · Archive pending
Vendor language on provider benefit
- “Earn Commissions.Sign up Amazon Associates - Amazon’s affiliate marketing program Welcome to one of the largest affiliate marketing programs in the world.”
- “Earn Commissions.Sign up Operating agreement Program policies Conditions of use Contact us © 1996-2025, Amazon.com, Inc.”
Supplements pitched
- Brain Defenders by David Perlmutter
“Brain Defenders by Dr. David Perlmutter: https://www.amazon.com/Brain-Defender...”
How the money flows
- Affiliate / promo linkUndisclosed An Amazon link to the guest's book is present, and the page contains an affiliate-disclaimer heading, but the exact commission relationship is not stated on the video surface. “Brain Defenders by Dr. David Perlmutter: https://www.amazon.com/Brain-Defender...”
“Brain Defenders by Dr. David Perlmutter: https://www.amazon.com/Brain-Defender...”
- Coaching or consult upsellUndisclosed The host promotes a fasting guide, a paid event, and a commercial book ecosystem associated with her brand. “Download my FREE Fasting 101 Guide”
“Download my FREE Fasting 101 Guide”
Store links detected
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Learn: Is a chiropractor a medical doctor?
Credentials and scope reflect the dossier-wide determination for this subject, drawn from the strongest verified material across every analyzed source.
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: D.C · Chiropractor · CA license DC24553.
The clip provides no stated degree, license, or professional credential for Mindy Pelz. Credential legitimacy and scope cannot be assessed from this title-and-description-only content.
- Chiropractor (DC), Doctor of Chiropractic
California DCs may use limited adjunctive modalities within board rules but cannot practice medicine, prescribe legend drugs, or hold out as physicians. Functional-medicine-style disease treatment typically exceeds scope.
Permitted scope vs advertised
California Board of Chiropractic Examiners · Confidence: high
California chiropractors may manipulate and adjust the spinal column and other joints, use mechanical and hygienic measures as part of chiropractic treatment, treat any condition or disease, and diagnose—but only when done consistent with chiropractic methods and techniques and without exceeding the legal scope of chiropractic practice. Chiropractors may not practice medicine, surgery, use drugs in materia medica, or perform obstetrics.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
6 of 6 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Alzheimer’s disease Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) Diagnosing Alzheimer's disease—a systemic neurodegenerative disease—exceeds chiropractic scope because such diagnosis constitutes the practice of medicine and is not consistent with chiropractic methods and techniques focused on the musculoskeletal system and its relationship to the nervous system. | Outside scope |
| Metabolic health is one of the most important pieces of the explanation for women’s Alzheimer’s risk. Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) Making etiological claims about Alzheimer's disease and metabolic factors constitutes medical diagnosis and disease explanation beyond chiropractic scope, as it addresses systemic disease pathophysiology rather than musculoskeletal or chiropractic-method-consistent treatment. | Outside scope |
| Menopause may increase vulnerability to brain aging or Alzheimer’s disease. Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) Claiming a causal or risk relationship between menopause and Alzheimer's disease constitutes medical diagnosis and disease etiology explanation outside chiropractic scope, as it addresses systemic endocrine and neurological disease mechanisms. | Outside scope |
| Blood sugar, insulin resistance, visceral fat, inflammation, and mitochondrial health influence brain aging. Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) Explaining systemic metabolic and cellular mechanisms of brain aging constitutes medical diagnosis and disease pathophysiology explanation beyond chiropractic scope, which is limited to musculoskeletal and chiropractic-method-consistent treatment. | Outside scope |
| Listed service The Menopause Reset Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) A treatment program branded as 'The Menopause Reset' that addresses menopause and its systemic effects exceeds chiropractic scope because menopause management is a medical/endocrine condition outside the musculoskeletal and chiropractic-method-consistent treatment domain. | Outside scope |
| Listed service Hormones & Menopause Rule: Cal. Code Regs. Tit. 16, § 302(a)(3) Advertising services focused on hormones and menopause management constitutes medical treatment of an endocrine/systemic condition outside chiropractic scope, which does not authorize hormone management or primary treatment of menopause. | Outside scope |
Sources: California Code of Regulations, Title 16, Section 302 - Practice of Chiropractic, California Board of Chiropractic Examiners - Laws and Regulations (official), California Business and Professions Code Section 1000 et seq., Rules and Regulations (official)
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drmindypelz.com)
- OwnedLinked commerce or practice (levels.link)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission miwxZuv04ewyFWtp15lze
Fight disinformation
Log a public thread where Mindy Hetzer Pelz is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Mindy Hetzer Pelz's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/miwxZuv04ewyFWtp15lze. White-coat charisma isn't evidence.
Full DTMB scan on Mindy Hetzer Pelz: https://drtrustmebro.com/analyze/miwxZuv04ewyFWtp15lze
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Mindy Hetzer Pelz can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Mindy Hetzer Pelz, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Mindy Hetzer Pelz. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: 2wwzZmV28lAwxpLnSwSWM
- Wall entry: /influencer/2wwzZmV28lAwxpLnSwSWM
- Analysis ID: miwxZuv04ewyFWtp15lze
- Source: https://www.youtube.com/watch?v=MtxLcmMfPPQ
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Influence of the Onset of Menopause on the Risk ... - PMC - NIH
- [2] Systematic review and meta-analysis of the effects of ... - PMC
- [3] Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
- [4] Systematic review and meta-analysis of the effects of menopause ...
- [5] Metabolic syndrome and risk of incident all-cause dementia, Alzheimer's disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies - PubMed
- [6] Metabolic Syndrome and the Risk of Alzheimer's Disease: A Meta-Analysis - PubMed
- [7] Associations of metabolic syndrome with risks of dementia ...
- [8] Metabolic syndrome and risk of dementia and cognitive decline: a systematic review and meta-analysis of prospective cohort studies from 6,753,197 participants - PubMed
- [9] Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia - PubMed
- [10] Insulin resistance as a key link for the increased risk of cognitive ... - PMC
- [11] Mitochondria and brain aging: From cell-specific dysfunction ...
- [12] Diabetes Mellitus and Cognitive Decline: A Systematic ...
- [13] Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
- [14] Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.
- [15] Tailoring transdermal estradiol dose to maximize benefits and minimize risks.
- [16] International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause.
- [17] Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
- [18] Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
- [19] Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.
- [20] Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
- [21] European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause
- [22] Clinical Practice Guidelines on Menopause: *An Executive ...
- [23] Introduction to Clinical Practice Guidelines for Menopause 2026
- [24] Treatment of Symptoms of the Menopause: An Endocrine ...